Ataxia-oculomotor Apraxia Type 1

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-11-06
Clinical Trial Update: Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 [Phase 3]
Phase 3 trial assessing albumin evolution in patients with ataxia-oculomotor apraxia type 1 who received Coenzyme Q10 has completed.